Role of N343 glycosylation on the SARS-CoV-2 S RBD structure and co-receptor binding across variants of concern

  1. Callum M Ives
  2. Linh Nguyen
  3. Carl A Fogarty
  4. Aoife M Harbison
  5. Yves Durocher
  6. John Klassen  Is a corresponding author
  7. Elisa Fadda  Is a corresponding author
  1. Department of Chemistry, Maynooth University, Ireland
  2. Department of Chemistry, University of Alberta, Canada
  3. Human Health Therapeutics Research Centre, Life Sciences Division, National Research Council Canada, Canada
  4. Département de Biochimie et Médecine Moléculaire, Université de Montréal, Canada
  5. School of Biological Sciences, University of Southampton, United Kingdom
10 figures, 11 tables and 1 additional file

Figures

Structure of the SARS-CoV-2 (WHu-1) Spike (S) glycoprotein and of the receptor binding domain (RBD) with a heat map of the interactions between the N343 glycan and the RBD in different variants of concern.

(a) Atomistic model of the SARS-CoV-2 (WHu-1) S glycoprotein trimer embedded in a lipid bilayer as reported in Casalino et al., 2020. In the conformation shown, the S bears the receptor binding …

Conformational changes of the S receptor binding domain (RBD) structure in function of loss of N-glycosylation at N343 in WHu-1, alpha and beta variants and binding affinities for interactions between different RBDs and GM1/2os.

(a) Kernel density estimates (KDE) plot of the backbone RMSD values calculated relative to frame 1 (t=0) of the trajectory for Region 1 (green) aa 337–353, Region 2 (yellow) aa 439–506, and Region 3 …

Conformational analysis and 3D structure of the S receptor binding domain (RBD) in the delta variant glycosylated at N343 with a diagram showing binding affinity to GM1/2os in the presence and absence of the glycan at N343 and in the omicron variant.

(a) Kernel density estimates (KDE) plot of the backbone RMSD values calculated relative to frame 1 (t=0) of the MD trajectories (MD1) trajectory for Region 1 (green) aa 337–353, Region 2 (yellow) aa …

Conformational dynamics of the BA.1 and BA.2.86 S receptor binding domain (RBD) in function of N343 glycosylation.

(a) Kernel density estimates (KDE) plot of the backbone RMSD values calculated relative to frame 1 (t=0) of the gaussian accelerated MD (GaMD) trajectory for Region 1 (green) aa 337–353, Region 2 …

Appendix 1—figure 1
Amino acid sequence of SARS-CoV-2 spike (S) protein variants and mutations on receptor binding domain (RBD) used in this study.
Appendix 1—figure 2
Conformational dynamics of the WHu-1 receptor binding domain (RBD) in function of N343 glycosylation.

(a) Kernel density estimates (KDE) plots of the backbone RMSD values calculated relative to frame 1 (t=0) of the gaussian accelerated MD (GaMD) trajectory for Region 1 (green) aa 337–353, Region 2 …

Appendix 1—figure 3
Bar plot of the interaction frequencies (%) of the N343 N-glycan with the different residues within the aa 365–375 loop for each variants of concern (VoC).

The interactions include both hydrogen bonding and dispersion (van der Waals) contacts.

Appendix 1—figure 4
Conformational dynamics of the delta receptor binding domain (RBD) in function of N343 glycosylation.

(a) Kernel density estimates (KDE) plot of the backbone RMSD values calculated relative to frame 1 (t=0) of the MD1 trajectory for Region 1 (green) aa 337–353, Region 2 (yellow) aa 439–506, and …

Appendix 1—figure 5
Relative abundance of N-glycans at N331 and N343 on the wild-type (WT) receptor binding domain (RBD) before and after endoF3 treatment.
Appendix 1—figure 6
Conformational dynamics of the BA.1 receptor binding domain (RBD) in function of N343 glycosylation.

(a) Kernel density estimates (KDE) plot of the backbone RMSD values calculated relative to frame 1 (t=0) of the MD1 (left) and MD2 (right) trajectories for Region 1 (green) aa 337–353, Region 2 …

Tables

Appendix 1—table 1
Molecular dynamics (MD) sampling methods and corresponding times in the production phase of the simulations.

MD1 and MD2 indicate trajectories collected through conventional (deterministic) sampling. Gaussian accelerated MD (GaMD) indicates trajectories obtained through Gaussian accelerated MD sampling. …

N343-FA2G2 (μs)N343 NoGly (μs)
VariantMD1MD2GaMDMD1MD2GaMD
WHu-12.52.02.03.02.02.0
Alpha (B.1.1.7)2.0---2.0-
Beta (B.1.351)2.0---2.0-
Delta (B.1.617.2)2.02.02.03.0-2.0
Omicron (BA.1)2.02.02.02.02.02.0
Omicron (BA.2.86)2.0-----
Total (46.5)12.56.06.08.08.06.0
Appendix 1—table 2
Affinities of the oligosaccharides of GM1 and GM2 (GM1os and GM2os, respectively) for WHu-1, Alpha, Beta, Delta, and Omicron receptor binding domain (RBD) and endoH-treated WHu-1 RBD and endoF3-treated WHu-1 and Delta RBD measured by ESI-MS for aqueous ammonium acetate (100 mM, pH 7.4) solutions containing a given RBD (5 μM) and glycan (three different initial concentrations ranging from 10 μM to 150 μM).

Data represent mean ± SD; n = 3 independent experiments for each glycan concentration.

VariantGM1os Kd (mM)GM2os Kd (mM)
WHu-1 RBD (sample 1; HEK293-a)0.16 ± 0.040.17 ± 0.02
WHu-1 RBD (sample 2; HEK293-a)0.18 ± 0.010.22 ± 0.03
WHu-1 RBD (sample 3; HEK293-b)0.07 ± 0.010.09 ± 0.02
endoF3-treated WHu-1 RBD (HEK293-b)3.6 ± 0.75.7 ± 0.6
alpha (HEK293-b)0.15 ± 0.030.16 ± 0.03
beta (HEK293-b)1.3 ± 0.41.10 ± 0.2
delta (HEK293-b)0.11 ± 0.010.08 ± 0.02
endoF3-treated delta (HEK293-b)0.12 ± 0.010.06 ± 0.01
micron (HEK293-b)1.1 ± 0.20.70 ± 0.16
Appendix 1—table 3
Summary of molecular weights (MWs) of WHu-1 receptor binding domain (RBD) glycoforms (WTx) with respective relative abundances identified by ESI-MS and putative H_N_F_S combinations.
RBDMeasuredMW (Da)Relative abundanceH_N_F_S combinationTheoretical MW (Da)Mass difference (Da)
WT131342.425.59_11_2_031345.15.3
WT231402.42.611_9_1_131408.02.4
WT331505.242.79_9_0_331520.16.9
WT431527.034.310_9_1_231537.12.1
WT531609.419.011_10_3_031612.15.3
WT631668.848.810_9_0_331682.15.4
WT731690.256.211_9_1_231699.11.0
WT831711.417.89_10_0_331723.23.7
WT931771.143.912_10_3_031774.24.9
WT1031794.065.610_11_0_231797.24.8
WT1131816.526.510_9_1_331828.23.7
WT1231835.330.611_9_2_231845.21.9
WT1331854.444.69_10_1_331869.26.8
WT1431875.247.510_10_2_231886.23.1
WT1531896.435.811_10_1_231902.22.2
WT1631935.85.610_11_1_231943.30.6
WT1731957.885.011_11_0_231959.26.6
WT1831979.798.113_11_0_131992.34.6
WT1931001.261.39_10_2_332015.36.1
WT2032038.717.311_10_0_332047.30.6
WT2132060.155.712_10_1_232064.33.9
WT2232083.355.910_11_0_332088.33.0
WT2332105.51.112_11_0_232121.37.8
WT2432125.112.613_11_1_132138.35.2
WT2532144.372.610_12_1_232146.35.9
WT2632165.063.512_12_1_132179.36.4
WT2732185.739.811_10_1_332193.30.4
WT2832247.888.411_11_0_332250.35.5
WT2932270.3100.013_11_0_232283.45.1
WT3032291.862.412_14_1_032294.45.4
WT3132348.858.712_10_1_332355.41.4
WT3232371.546.610_11_0_432379.40.1
WT3332434.469.710_12_1_332437.45.0
WT3432456.176.412_12_1_232470.46.3
WT3532477.043.611_10_1_432484.40.6
WT3632538.278.011_11_0_432541.44.8
WT3732560.979.613_11_0_332574.45.6
WT3832583.049.512_14_1_132585.55.5
WT3932615.219.111_10_0_532629.56.3
WT4032637.960.512_10_1_432646.50.6
WT4132659.639.010_11_0_532670.52.9
WT4232725.455.210_12_1_432728.54.9
WT4332747.758.212_12_1_332761.55.8
WT4432768.84.111_10_1_532775.51.3
WT4532826.81.711_11_0_532832.52.3
WT4632851.510.713_11_0_432865.56.1
WT4732873.74.312_14_1_232876.65.1
WT4832927.549.512_10_1_532937.62.1
WT4932949.815.610_11_0_632961.63.8
WT5033293.534.613_11_1_533302.71.2
WT5133583.89.413_11_1_633593.82.0
Appendix 1—table 4
Summary of molecular weights (MWs) of B.1.1.7 receptor binding domain (RBD) glycoforms (Alpha, Ax) with respective relative abundances identified by ESI-MS and putative H_N_F_S combinations.
RBDMeasuredMW (Da)Relative abundanceH_N_F_S combinationTheoretical MW (Da)Mass difference (Da)
A130894.66.49_10_0_030899.04.3
A231080.717.19_8_2_131076.04.7
A331137.85.39_9_3_031134.13.7
A431160.23.29_7_2_231164.03.8
A531184.93.79_10_0_131190.15.2
A631243.113.010_8_2_131238.15.1
A731265.910.910_11_0_031264.11.8
A831300.54.510_9_3_031296.14.4
A931319.63.48_10_2_131320.10.5
A1031346.62.610_10_0_131352.15.5
A1131369.519.411_10_1_031369.10.4
A1231405.126.48_9_2_231408.13.0
A1331427.313.611_11_0_031426.11.1
A1431449.44.97_10_4_131450.20.8
A1531482.04.69_10_2_131482.20.1
A1631505.73.47_11_3_131507.21.5
A1731529.130.912_10_1_031531.22.0
A1831553.535.310_11_0_131555.21.7
A1931590.827.812_11_0_031588.22.6
A2031611.616.58_10_2_231611.20.4
A2131658.99.811_10_3_031661.22.3
A2231693.98.813_10_1_031693.20.6
A2331715.296.911_11_0_131717.22.0
A2431737.613.712_11_1_031734.33.3
A2531773.319.89_10_2_231773.30.1
A2631793.913.412_12_0_031791.32.7
A2731819.931.412_10_1_131822.32.4
A2831844.420.410_11_0_231846.31.9
A2931880.113.312_11_0_131879.30.8
A3031901.178.68_10_4_231903.32.3
A3131920.84.811_12_0_131920.30.5
A3231937.32.712_12_1_031937.30.1
A3331957.610.813_12_0_031953.34.2
A3431978.110.09_11_2_231976.31.7
A3531006.1100.011_11_0_231008.32.2
A3632027.75.212_11_3_032026.41.3
A3732061.84.99_10_2_332064.42.6
A3832081.453.512_12_0_132082.41.0
A3932109.610.512_10_1_232113.43.8
A4032137.513.810_11_2_232138.40.9
A4132191.882.813_11_3_032188.43.4
A4232212.73.211_12_0_232211.41.3
A4332227.52.612_12_1_132228.41.0
A4432266.539.19_11_2_332267.40.9
A4532297.948.211_11_0_332299.41.5
A4632372.053.512_12_0_232373.51.5
A4732393.95.011_10_4_232389.54.4
A4832446.431.211_11_1_332445.50.9
A4932483.135.213_11_3_132479.53.6
A5032504.34.711_12_2_232503.50.7
A5132557.243.914_12_3_032553.63.7
A5232590.010.011_11_2_332591.51.6
A5332631.825.210_12_2_332632.60.8
A5432663.534.612_12_0_332664.61.1
A5532707.14.511_13_2_232706.60.5
A5632737.244.711_11_1_432736.60.6
A5732774.46.213_11_3_232770.63.8
A5832811.621.612_12_1_332810.60.9
A5932848.224.614_12_3_132844.73.6
A6032869.84.812_13_2_232868.71.2
A6132887.83.513_13_1_232884.73.1
A6232922.734.710_12_2_432923.71.0
A6332954.711.512_12_0_432955.71.0
A6432998.016.211_13_2_332997.70.3
A6533028.428.511_11_1_533027.70.7
A6633050.43.312_11_4_333045.74.7
A6733072.54.012_14_2_233071.70.7
A6833102.630.212_12_1_433101.70.8
A6933138.58.114_12_3_233135.72.8
A7033176.816.513_13_1_333175.81.0
A7133213.222.715_13_3_133207.85.5
A7233250.33.812_12_2_433247.82.5
A7333288.023.116_14_3_033283.84.1
A7433320.012.611_11_3_533319.80.2
A7533362.313.412_14_2_333362.80.5
A7633393.821.412_12_1_533392.81.0
A7733467.924.313_13_1_433466.81.0
A7833504.48.715_13_3_233500.93.5
A7933542.511.614_14_1_333540.91.6
A8033578.215.716_14_3_133574.93.3
A8133613.24.613_13_0_533611.91.3
A8233653.018.212_14_2_433653.90.9
A8333685.18.214_14_2_333686.91.9
A8433727.911.911_13_3_533726.01.9
A8533759.217.413_13_1_533757.91.3
A8633833.416.814_14_1_433832.01.4
A8733868.97.316_14_1_333865.03.9
A8833907.011.813_13_0_633903.04.0
A8933944.012.413_13_0_633945.01.0
A9034018.614.812_14_2_534018.00.6
A9134051.110.313_13_3_534050.11.0
A9234125.011.114_14_1_534123.12.0
A9334198.19.513_13_0_734194.14.0
A9434309.07.913_15_0_634309.10.2
A9534599.33.513_15_2_634601.32.0
A9634823.32.216_13_1_734826.33.0
A9734886.38.716_14_2_634884.32.0
Appendix 1—table 5
Summary of molecular weights (MWs) of B.1.351 receptor binding domain (RBD) glycoforms (Beta, Bx) with respective relative abundances identified by ESI-MS and putative H_N_F_S combinations.
RBDMeasuredMW (Da)Relative abundanceH_N_F_S combinationTheoretical MW (Da)Mass difference (Da)
B131247.710.69_9_0_231255.07.3
B231352.518.210_8_1_231360.07.6
B331376.312.99_11_0_131370.06.2
B431408.625.911_11_0_031403.15.5
B531433.016.911_9_1_131434.01.0
B631512.719.69_11_1_131516.13.4
B731538.162.39_9_0_331546.18.0
B831559.87.010_9_1_231563.13.2
B931595.634.79_10_1_231604.18.6
B1031616.59.910_10_0_231620.13.6
B1131641.711.011_10_1_131637.14.6
B1231669.215.413_10_1_031670.10.9
B1331700.2100.010_9_0_331708.17.9
B1431723.864.411_9_1_231725.11.3
B1531758.710.910_10_1_231766.27.5
B1631778.516.211_10_0_231782.23.7
B1731803.012.512_10_1_131799.23.8
B1831829.542.910_11_2_131824.25.3
B1931886.184.912_9_1_231887.21.1
B2031906.032.110_10_0_331911.25.2
B2131962.022.610_11_1_231969.37.2
B2231991.358.710_9_2_331000.28.9
B2332014.831.811_9_1_332016.21.5
B2432066.453.911_10_0_332073.36.9
B2532089.436.312_10_1_232090.30.9
B2632142.210.012_11_0_232147.35.1
B2732177.045.912_9_1_332178.31.3
B2832196.721.810_10_0_432202.35.6
B2932251.548.113_10_1_232252.30.9
B3032271.110.111_11_0_332276.35.3
B3132326.414.914_11_1_132326.40.1
B3232356.433.311_10_0_432364.48.0
B3332379.527.612_10_1_332381.41.9
B3432431.348.812_11_0_332438.47.1
B3532454.729.511_9_2_432453.41.3
B3632541.624.413_10_1_332543.41.8
B3732560.920.811_11_0_432567.46.6
B3832617.143.114_11_1_232617.50.4
B3932637.19.612_12_0_332641.54.4
B4032722.135.212_11_0_432729.57.4
B4132744.817.213_11_1_332746.51.7
B4232796.834.111_10_1_532801.54.7
B4332820.313.612_10_2_432818.51.8
B4432927.09.012_12_0_432932.65.6
B4532983.030.013_10_2_432980.62.4
B4633109.910.912_10_2_533109.60.3
B4733162.326.912_11_1_533166.64.4
B4833273.521.213_10_2_533271.71.8
B4933348.127.514_11_2_433345.72.4
B5033452.724.312_11_1_633457.75.1
B5133528.025.513_12_1_533531.83.8
B5233637.917.314_11_2_533636.81.1
B5333713.120.713_10_3_633708.84.3
B5433817.921.013_12_1_633822.95.0
B5533893.017.014_13_1_533896.93.9
B5634003.313.813_10_3_733999.93.4
B5734183.010.014_13_1_634188.05.0
B5834548.77.715_14_1_634553.14.5
B5934693.113.515_14_2_634699.26.1
Appendix 1—table 6
Summary of molecular weights (MWs) of B.1.351.2 receptor binding domain (RBD) glycoforms (Delta, Dx) with respective relative abundances identified by ESI-MS and putative H_N_F_S combinations.
RBDMeasuredMW (Da)Relative abundanceH_N_F_S combinationTheoretical MW (Da)Mass difference (Da)
D131073.520.98_11_1_031079.05.5
D231094.31.09_11_0_031095.00.7
D331259.924.310_11_0_031257.12.8
D431363.728.68_11_1_131370.16.4
D531423.023.411_11_0_031419.13.9
D631526.226.69_11_1_131532.25.9
D731548.325.410_11_0_131548.20.2
D831654.229.48_11_1_231661.27.0
D931690.523.910_11_1_131694.23.7
D1031711.439.311_11_0_131710.21.2
D1131733.516.19_12_1_131735.21.7
D1231813.833.610_13_1_031809.34.5
D1331838.031.010_11_0_231839.31.3
D1431875.913.212_11_2_031873.32.6
D1531895.225.710_12_1_131897.32.1
D1631979.430.510_11_1_231985.35.9
D1731000.660.711_11_0_231001.30.8
D1832022.026.09_12_1_232026.34.3
D1932079.625.412_12_0_132075.34.2
D2032104.249.010_13_1_132100.43.8
D2132127.529.310_11_0_332130.32.8
D2232164.94.612_11_0_232163.41.6
D2332185.444.810_12_1_232188.43.0
D2432206.85.011_12_0_232204.42.4
D2532290.990.611_11_0_332292.41.5
D2632312.432.49_12_1_332317.45.1
D2732348.426.011_12_1_232350.42.1
D2832369.134.112_12_0_232366.42.7
D2932394.445.510_13_1_232391.53.0
D3032475.950.010_12_1_332479.53.5
D3132496.522.211_12_0_332495.51.0
D3232553.60.711_13_1_232553.50.1
D3332581.7100.011_11_0_432583.51.8
D3432603.734.712_11_3_232601.52.2
D3532638.20.311_12_1_332641.53.3
D3632658.441.312_12_0_332657.50.8
D3732683.321.810_13_1_332682.60.7
D3832766.441.910_12_1_432770.64.2
D3932843.08.011_13_1_332844.61.7
D4032873.468.511_11_0_532874.61.2
D4132895.218.512_11_3_332892.62.6
D4232948.245.112_12_0_432948.60.4
D4333238.942.512_12_0_533239.70.8
D4433313.930.213_13_0_433313.80.1
D4533604.637.113_13_0_533604.90.2
D4633896.129.513_13_0_633896.00.2
D4733969.99.212_12_3_633969.00.9
D4834186.421.613_13_0_734187.00.7
D4934260.39.014_14_0_634261.10.7
Appendix 1—table 7
Summary of molecular weights (MWs) of B.1.1.529 receptor binding domain (RBD) glycoforms (Omicron, Ox) with respective relative abundances identified by ESI-MS and putative H_N_F_S combinations.
RBDMeasuredMW (Da)Relative abundanceH_N_F_S combinationTheoretical MW (Da)Mass difference (Da)
O132489.240.210_11_1_332487.61.5
O232538.445.711_9_3_332535.72.7
O332559.45.611_12_1_232561.72.3
O432576.023.010_10_1_432575.70.3
O532595.174.611_10_2_332592.72.4
O632615.431.412_10_1_332608.76.7
O732651.129.011_11_1_332649.71.4
O832670.224.912_11_2_232666.73.4
O932702.342.511_12_0_332706.74.4
O1032723.887.110_10_2_432721.72.1
O1132744.02.511_10_3_332738.75.3
O1232761.011.312_10_2_332754.76.3
O1332779.853.610_11_1_432778.71.1
O1432798.723.011_11_2_332795.82.9
O1532829.162.111_9_3_432826.82.3
O1632852.527.611_12_1_332852.80.3
O1732885.785.711_10_2_432883.82.0
O1832905.729.712_10_3_332900.84.9
O1932942.212.111_11_1_432940.81.4
O2032960.840.812_11_2_332957.83.0
O2133014.9100.012_12_1_333014.80.1
O2233035.625.511_10_3_433029.85.8
O2333070.252.112_13_0_333071.91.6
O2433089.852.711_11_2_433086.92.9
O2533120.452.413_11_2_333119.90.6
O2633144.728.311_12_1_433143.90.8
O2733177.550.711_10_2_533174.92.6
O2833195.933.212_10_3_433191.94.0
O2933217.413.212_13_1_333217.90.5
O3033233.91.611_11_1_533231.92.0
O3133251.658.412_11_2_433248.92.7
O3233271.215.413_11_3_333265.95.2
O3333306.183.212_12_1_433305.90.2
O3433326.728.913_12_2_333322.93.7
O3533361.530.312_13_0_433362.91.4
O3633380.861.413_13_1_333380.00.9
O3733402.50.314_13_0_333396.06.5
O3833435.927.511_12_1_533435.00.9
O3933454.815.112_12_2_433452.02.8
O4033486.224.514_12_0_433484.02.2
O4133508.318.312_13_1_433509.00.7
O4233542.137.012_11_2_533540.02.1
O4333561.524.815_13_0_333558.03.5
O4433597.525.212_12_1_533597.00.5
O4533617.333.113_12_2_433614.03.2
O4633671.847.213_13_1_433671.10.7
O4733691.716.414_13_0_433687.14.6
O4833726.313.713_14_0_433728.11.7
O4933745.735.312_12_2_533743.12.6
O5033776.216.114_12_2_433776.10.1
O5133800.417.012_13_1_533800.10.3
O5233833.83.014_13_1_433833.10.7
O5333851.728.415_13_0_433849.12.6
O5433874.510.313_14_1_433874.10.4
O5533907.821.713_12_2_533905.12.7
O5633927.214.414_12_3_433922.15.0
O5733963.127.113_13_1_533962.20.9
O5833982.313.714_13_0_533978.14.2
O5934037.032.614_14_1_434036.20.8
O6034058.23.713_12_3_534051.27.0
O6134090.98.812_13_1_634091.20.3
O6234110.911.613_13_2_534108.22.7
O6334142.722.515_13_0_534140.22.5
O6434165.65.113_14_1_534165.20.4
O6534199.36.615_14_1_434198.21.1
O6634217.120.914_12_1_634212.24.8
O6734274.920.814_13_2_534270.34.6
O6834327.526.714_14_1_534327.30.2
O6934346.615.513_12_3_634342.34.3
O7034384.50.913_10_4_734373.311.2
O7134402.423.313_13_2_634399.33.1
O7234457.19.013_14_1_634456.30.8
O7334506.718.814_12_1_734503.33.4
O7434529.73.112_13_4_634529.40.3
O7534564.325.014_13_0_734560.34.0
O7634620.026.614_14_1_634618.41.6
O7734638.423.015_14_2_534635.43.0
O7834658.812.716_14_3_434652.46.4
O7934768.40.914_14_2_634764.44.0
O8034798.629.814_12_1_834794.44.2
O8134840.40.513_13_3_734836.54.0
O8234858.920.414_13_0_834851.47.5
O8335019.814.515_13_0_835013.56.3
O8435041.210.513_14_3_735039.51.7
O8535220.723.815_14_0_835216.64.1
O8635312.32.615_13_2_835305.66.7
O8735354.019.815_14_1_835362.68.6
Appendix 1—table 8
Summary of molecular weights (MWs) of endoF3-treated WHu-Hu-1 receptor binding domain (RBD) glycoforms (eWTx) with respective relative abundances identified by ESI-MS and putative H_N_F_S combinations.
RBDMeasuredMW (Da)Relative abundanceH_N_F_S combinationTheoretical MW (Da)Mass difference (Da)Number of trimmed N-glycans
eWT128116.94.51_3_0_028123.97.02
eWT228243.926.43_2_0_028244.91.02
eWT328357.314.51_2_1_128358.00.62
eWT428618.023.81_4_2_028619.11.02
eWT528881.12.43_3_1_128885.14.02
eWT629029.218.73_3_2_129031.22.12
eWT729143.81.16_4_0_029137.26.51
eWT829318.21.15_5_1_029324.36.11
eWT929406.58.25_4_1_129412.35.81
eWT1029454.514.14_5_1_129453.41.21
eWT1129649.40.67_5_1_029648.41.01
eWT1229736.39.65_7_1_029730.55.81
eWT1329753.51.35_5_0_229760.56.91
eWT1430084.91.37_5_2_130085.60.71
eWT1530103.410.35_6_1_230109.66.21
eWT1631033.027.68_6_2_331032.90.11
eWT1731216.417.27_7_1_431219.02.51
eWT1831416.88.07_8_1_431422.05.21
eWT1931437.40.98_8_0_431438.00.71
eWT2031482.39.07_9_2_331480.12.21
eWT2131505.738.49_9_0_331512.16.40
eWT2231543.341.09_7_1_431543.10.21
eWT2331564.855.27_8_2_431568.13.31
eWT2431607.42.211_10_3_031604.13.20
eWT2531644.127.38_9_2_331642.12.01
eWT2631668.282.810_9_0_331674.15.90
eWT2731691.033.811_9_1_231691.10.20
eWT2831708.49.99_10_0_331715.26.70
eWT2931727.658.610_10_1_231732.24.50
eWT3031748.342.711_10_0_231748.20.10
eWT3131770.929.212_10_3_031766.24.70
eWT3231795.925.710_11_0_231789.26.70
eWT3331833.635.011_9_2_231837.23.60
eWT3431854.495.99_10_1_331861.26.80
eWT3531872.614.110_10_2_231878.25.60
eWT3631893.51.511_10_1_231894.20.70
eWT3731912.951.612_10_0_231910.22.60
eWT3831933.226.110_11_1_231935.32.00
eWT3931958.1100.011_11_0_231951.26.90
eWT4031980.428.513_11_0_131984.33.90
eWT4132017.736.810_10_1_332023.35.50
eWT4232060.96.212_10_1_232056.34.60
Appendix 1—table 9
Summary of molecular weights (MWs) of endoF3-treated B.1.351.2 receptor binding domain (RBD) glycoforms (eDx) with respective relative abundances identified by ESI-MS and putative H_N_F_S combinations.
RBDMeasuredMW (Da)Relative abundanceH_N_F_S combinationTheoretical MW (Da)Mass difference (Da)Number of trimmed N-glycans
eD128681.82.24_3_0_028680.11.72
eD228720.324.93_4_0_028721.10.82
eD328741.835.32_2_2_128736.15.62
eD428762.69.42_5_0_028762.20.52
eD528782.333.51_3_2_128777.25.22
eD628803.625.93_3_2_028810.26.52
eD728826.219.84_3_1_028826.20.12
eD828867.382.43_4_1_028867.20.12
eD928888.252.64_4_0_028883.25.02
eD1028907.620.63_2_2_128898.29.42
eD1128927.8100.03_5_0_028924.23.62
eD1228949.257.53_3_1_128955.26.02
eD1328970.638.34_3_0_128971.20.62
eD1428990.730.32_4_1_128996.25.52
eD1529011.632.33_4_0_129012.20.62
eD1629032.724.14_4_1_029029.23.52
eD1729053.652.13_2_1_229043.210.42
eD1829074.751.93_5_1_029070.34.42
eD1929095.115.73_3_2_129101.36.22
eD2029114.237.74_3_1_129117.33.12
eD2129135.126.02_4_0_229141.36.22
eD2229158.334.93_4_1_129158.30.02
eD2329179.725.34_4_2_029175.34.42
eD2429198.817.63_2_2_229189.39.62
eD2529219.243.73_5_0_129215.33.92
eD2629240.224.33_3_1_229246.36.12
eD2729261.416.44_3_2_129263.31.92
eD2829281.56.42_4_1_229287.35.92
eD2929301.31.93_4_2_129304.33.02
eD3029302.01.23_4_0_229303.31.32
eD3129344.924.85_4_2_029337.47.62
eD3229366.85.03_5_1_129361.45.52
eD3329405.710.14_3_1_229408.42.72
eD3429427.13.82_4_2_229433.46.32
Appendix 1—table 10
Glycopeptide analysis of wild-type (WT) receptor binding domain (RBD).
N-sitePeptide sequenceN-glycanRetention time (min)Measured m/zCharge stateMass accuracy (ppm)MS area
N331PNITNLCPFGEVA2S218.01170.4713–3.6688472
N331PNITNLCPFGEVA2S218.01755.7052–2.4870771
N331PNITNLCPFGEVA1G1F18.21354.57720.45157724
N331PNITNLCPFGEVA1G0F18.31273.55120.1485745
N331PNITNLCPFGEVA1S1F18.61500.12420.0465793
N331FPNITA2G2B27.81209.4892–2.7357370
N343GEVFNATRA2S1G1FB31.01579.1322–3.4344341
N343NATRFA2G2F6.31189.48420.33107145
N343NATRFA2G1F6.51107.95520.3046566
N343NATRFA2S1G1F7.01335.03220.7538217
N343PFGEVFNATRA2G213.51381.0762–3.29272764
N343PFGEVFNATRA2G113.61300.0492–3.69150239
N343PFGEVFNATRA2S1G113.71526.6232–2.90305875
N343PFGEVFNATRA2S1G013.81445.5972–3.53164686
Appendix 1—table 11
Glycopeptide analysis of endoF3-treated wild-type (WT) receptor binding domain (RBD).
N-sitePeptide sequenceN-glycanRetention time (min)Measured m/zCharge stateMass accuracy (ppm)MS area
N331PNITNLCPFGEVFA1G0F18.91347.5852–3.8821591
N331PNITNLCPFGEA2G0FB19.51427.0872–5.8183634
N331PNITNLCPFGEVA1G1F19.61354.5752–1.09112872
N331PNITNLCPFGEVA1G0F19.71273.5512–1.2152498
N331PNITNLCPFGEVA1S1F19.91500.1222–1.5159378
N331PNITNLCPFA2G126.2827.35031.3349111
N331PNITNLCPFA2G126.91240.52422.8125854
N331PNITNLA1G128.6964.91520.1919156
N343NATRFA2G2F6.31189.48320.5432460
N343NATRFA2G1F6.41107.95520.1947037
N343NATRFA2G0F6.51027.43020.5023831
N343NATRFA2S1G1F7.51335.03220.7534621
N343NATRFA2S2F7.81480.58021.0924974
N343NATRFGnF8.2957.45310.2817273
N343NATRFGnF8.2479.23020.53255747
N343NATRA2G018.0880.3632–2.334690
N343NATRFASVYA2S1G19.4736.56044.72103643
N343GEVFNATRGnF11.3621.79720.8314586
N343GEVFNATRGnF15.5414.86833.3915706
N343GEVFNATRGnF15.7414.86833.7818198
N343GEVFNATRFGnF17.6695.33121.2317392
N343GEVFNATRFA2G0F23.21243.53724.7617779

Additional files

Download links